Average Co-Inventor Count = 8.55
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Immatics Biotechnologies Gmbh (11 from 725 patents)
12 patents:
1. 12318407 - Peptides displayed by HLA for use in immunotherapy against different types of cancers
2. 12290530 - Peptides displayed by HLA for use in immunotherapy against different types of cancers
3. 12285443 - Peptides displayed by HLA for use immunotherapy against different types of cancers
4. 12274716 - Peptides displayed by HLA for use immunotherapy against different types of cancers
5. 12257269 - Peptides displayed by HLA for use in immunotherapy against different types of cancers
6. 12246039 - Peptides displayed by HLA for use in immunotherapy against different types of cancers
7. 11969464 - Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers
8. 11957716 - Peptides displayed by HLA for use in immunotherapy against different types of cancers
9. 11952409 - Amidated peptides and their deamidated counterparts displayed by non-HLA-A*02 for use in immunotherapy against different types of cancers preliminary class
10. 11904003 - Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers
11. 11891427 - Amidated peptides and their deamidated counterparts displayed by non-HLA-a*02 for use in immunotherapy against different types of cancers
12. 11833195 - Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers